BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 26014480)

  • 1. Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: discovery and computational modeling of a new series of ligands with nanomolar affinity.
    Anighoro A; Graziani D; Bettinelli I; Cilia A; De Toma C; Longhi M; Mangiarotti F; Menegon S; Pirona L; Poggesi E; Riva C; Rastelli G
    Bioorg Med Chem; 2015 Jul; 23(13):3040-58. PubMed ID: 26014480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors.
    Fu TT; Tu G; Ping M; Zheng GX; Yang FY; Yang JY; Zhang Y; Yao XJ; Xue WW; Zhu F
    Acta Pharmacol Sin; 2021 Aug; 42(8):1354-1367. PubMed ID: 33122823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Binding Mechanism of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators in Clinical Trials by Molecular Dynamics Simulations.
    Fu T; Zheng G; Tu G; Yang F; Chen Y; Yao X; Li X; Xue W; Zhu F
    ACS Chem Neurosci; 2018 Jun; 9(6):1492-1502. PubMed ID: 29522307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed In Vitro Pharmacological Characterization of Clinically Tested Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5.
    Arsova A; Møller TC; Vedel L; Hansen JL; Foster SR; Gregory KJ; Bräuner-Osborne H
    Mol Pharmacol; 2020 Jul; 98(1):49-60. PubMed ID: 32358164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7TM X-ray structures for class C GPCRs as new drug-discovery tools. 1. mGluR5.
    Topiol S; Sabio M
    Bioorg Med Chem Lett; 2016 Jan; 26(2):484-494. PubMed ID: 26706173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated In Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5.
    Bian Y; Feng Z; Yang P; Xie XQ
    AAPS J; 2017 Jul; 19(4):1235-1248. PubMed ID: 28560482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual Screening and Molecular Dynamics Study of Potential Negative Allosteric Modulators of mGluR1 from Chinese Herbs.
    Jiang L; Zhang X; Chen X; He Y; Qiao L; Zhang Y; Li G; Xiang Y
    Molecules; 2015 Jul; 20(7):12769-86. PubMed ID: 26184151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding.
    Butkiewicz M; Rodriguez AL; Rainey SE; Wieting J; Luscombe VB; Stauffer SR; Lindsley CW; Conn PJ; Meiler J
    ACS Chem Neurosci; 2019 Aug; 10(8):3427-3436. PubMed ID: 31132237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling the Structural Determinants of Aryl Benzamide Derivatives as Negative Allosteric Modulators of mGluR5 by In Silico Study.
    Zhao Y; Chen J; Liu Q; Li Y
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31963723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology.
    Sengmany K; Hellyer SD; Albold S; Wang T; Conn PJ; May LT; Christopoulos A; Leach K; Gregory KJ
    Neuropharmacology; 2019 May; 149():83-96. PubMed ID: 30763654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Based Optimization Strategies for G Protein-Coupled Receptor (GPCR) Allosteric Modulators: A Case Study from Analyses of New Metabotropic Glutamate Receptor 5 (mGlu
    Christopher JA; Orgován Z; Congreve M; Doré AS; Errey JC; Marshall FH; Mason JS; Okrasa K; Rucktooa P; Serrano-Vega MJ; Ferenczy GG; Keserű GM
    J Med Chem; 2019 Jan; 62(1):207-222. PubMed ID: 29455526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding Exposure-Receptor Occupancy Relationships for Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators across a Range of Preclinical and Clinical Studies.
    Bennett KA; Sergeev E; MacSweeney CP; Bakker G; Cooper AE
    J Pharmacol Exp Ther; 2021 Apr; 377(1):157-168. PubMed ID: 33541889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family.
    Feng Z; Ma S; Hu G; Xie XQ
    AAPS J; 2015 May; 17(3):737-53. PubMed ID: 25762450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of biological evaluation of pyrazole/imidazole amides as mGlu5 receptor negative allosteric modulators.
    Chae E; Shin YJ; Ryu EJ; Ji MK; Ryune Cho N; Lee KH; Jeong HJ; Kim SJ; Choi Y; Seok Oh K; Park CE; Soo Yoon Y
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2134-9. PubMed ID: 23434029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5).
    Martín-Martín ML; Bartolomé-Nebreda JM; Conde-Ceide S; Alonso de Diego SA; López S; Martínez-Viturro CM; Tong HM; Lavreysen H; Macdonald GJ; Steckler T; Mackie C; Bridges TM; Daniels JS; Niswender CM; Noetzel MJ; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1310-7. PubMed ID: 25683622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probe dependence and biased potentiation of metabotropic glutamate receptor 5 is mediated by differential ligand interactions in the common allosteric binding site.
    Hellyer SD; Sengmany K; Keller AN; Christopoulos A; Leach K; Gregory KJ
    Biochem Pharmacol; 2020 Jul; 177():114013. PubMed ID: 32389635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational analysis of negative and positive allosteric modulator binding and function in metabotropic glutamate receptor 5 (in)activation.
    Dalton JA; Gómez-Santacana X; Llebaria A; Giraldo J
    J Chem Inf Model; 2014 May; 54(5):1476-87. PubMed ID: 24793143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists.
    Johnson MP; Nisenbaum ES; Large TH; Emkey R; Baez M; Kingston AE
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):881-7. PubMed ID: 15494040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of specific ligand-receptor interactions that govern binding and cooperativity of diverse modulators to a common metabotropic glutamate receptor 5 allosteric site.
    Gregory KJ; Nguyen ED; Malosh C; Mendenhall JL; Zic JZ; Bates BS; Noetzel MJ; Squire EF; Turner EM; Rook JM; Emmitte KA; Stauffer SR; Lindsley CW; Meiler J; Conn PJ
    ACS Chem Neurosci; 2014 Apr; 5(4):282-95. PubMed ID: 24528109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAR studies on mGlu5 receptor positive allosteric modulators (2003- 2013).
    Hao J; Xiong H
    Curr Top Med Chem; 2014; 14(15):1789-841. PubMed ID: 25176124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.